Real-time CTC Profiling for Therapy Selection and Disease Monitoring
The Parsortix platform by CelLBxHealth is a next-generation microfluidic system designed to enrich and recover viable circulating tumor cells (CTCs) and CTC clusters from whole blood.
Using patented, label free technology within a single-use cassette, the Parsortix platform isolates cells based on size and deformability enabling the capture of a broad range of phenotypes, including mesenchymal and EMT-transitioning cells often missed by marker-dependent methods.
The Parsortix platform supports:
-
Real-time biomarker assessment
-
Therapy selection and resistance monitoring
-
Tumor evolution studies through repeatable, minimally invasive sampling
-
Drug discovery and development
-
Complementary analysis alongside ctDNA
Flexibility to Meet Your Needs
Bring the Parsortix platform into Your Laboratory
- Semi-automated microfluidic processing
- Cost-effective and repeatable liquid biopsy testing
- Integration into existing research and clinical diagnostic workflows
Or Partner with CelLBxHealth Lab Services
Our expert team will work with you to support your project using cutting-edge technology, eliminating the burden of capital equipment and operator training to provide:
- Custom assay development for real time biomarker assessment
- CTC enrichment using the Parsortix platform
- Comprehensive downstream analysis
Publications & Resources
Scientific Evidence
Discover More
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer
Open PDF